PARP
PARP(多聚ADP核糖聚合酶)
Poly (ADP-ribose) polymerases (PARPs) is a large family of proteins with a conserved catalytic domain that catalyze an immediate DNA-damage-dependent post-translational modification of histones and other nuclear proteins leading to the survival of injured proliferating cells. So far, a total number of 18 human PARP proteins encoded by different genes have been identified, including PARP-1 to PARP-4, PARP-5a, PARP-5b, PARP-5c and PARP-6 to PARP-16. The general structural of PARP proteins has been revealed through the extensive study of the founding family member PARP-1, which is characterized by the presence of four functional domains, including a DNA-binding domain, a caspase-cleaved domain, an automodification domain and a catalytic domain.
PARP 相关产品(120)
- GC13249Rucaparib (free base)CAS: 283173-50-2纯度: >99.00%
Rucaparib (free base)是一种口服生物可利用的三环吲哚类聚(ADP-核糖)聚合酶(PARP)抑制剂。
- GC15955Rucaparib (AG-014699,PF-01367338) phosphateCAS: 459868-92-9纯度: >99.50%
Rucaparib (AG-014699,PF-01367338) phosphate是一种口服生物可利用的三环吲哚类聚(ADP-核糖)聚合酶(PARP)抑制剂。
- GC34071Pamiparib (BGB-290)CAS: 1446261-44-4纯度: >99.50%
Pamiparib (BGB-290)是一种强效口服的聚腺苷二磷酸核糖聚合酶(PARP)抑制剂,对PARP-1和PARP-2的IC 50 值分别为1.3nM和0.9nM。
- GC34120Niraparib R-enantiomer (MK 4827 (R-enantiomer))CAS: 1038915-58-0纯度: >99.50%
Niraparib R-enantiomer (MK-4827 R-enantiomer) 是一种出色的 PARP1 抑制剂,IC50 为 2.4 nM。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC17965 | AZD2461 | 1174043-16-3 | >98.00% | |
A PARP inhibitor | ||||
| GC10456 | Fucosterol | 17605-67-3 | >98.00% | |
A natural phytosterol with diverse biological activities | ||||
| GC11761 | 4-amino-1,8-Naphthalimide | 1742-95-6 | >98.00% | |
A PARP inhibitor | ||||
| GC12781 | XAV-939 | 284028-89-3 | >98.50% / >98.00% | |
XAV-939 选择性抑制 β-连环蛋白介导的转录。 | ||||
| GC12844 | Benzamide | 55-21-0 | >99.50% | |
Benzamide (Benzenecarboxamide) 是一种有效的聚 (ADP-核糖) 聚合酶 (PARP) 抑制剂。 | ||||
| GC13249 | Rucaparib (free base) | 283173-50-2 | >99.00% | |
Rucaparib (free base)是一种口服生物可利用的三环吲哚类聚(ADP-核糖)聚合酶(PARP)抑制剂。 | ||||
| GC13541 | G007-LK | 1380672-07-0 | >99.00% | |
G007-LK是一种有效的、选择性的TNKS1(IC 50 =46nM)和TNKS2(IC 50 =25nM)抑制剂。 | ||||
| GC14251 | Picolinamide | 1452-77-3 | - | |
poly (ADP-ribose) synthetase inhibitor | ||||
| GC14380 | BGP-15 | 66611-37-8 | >98.00% | |
A PARP inhibitor and insulin sensitizer | ||||
| GC15932 | BMN 673 | 1207456-01-6 | >98.50% | |
BMN 673是一种新型且高效的聚ADP核糖聚合酶1和2(PARP1/2)抑制剂,对PARP1的K i 为1.2nM,对PARP2的K i 为0.87nM。 | ||||
| GC15955 | Rucaparib (AG-014699,PF-01367338) phosphate | 459868-92-9 | >99.50% | |
Rucaparib (AG-014699,PF-01367338) phosphate是一种口服生物可利用的三环吲哚类聚(ADP-核糖)聚合酶(PARP)抑制剂。 | ||||
| GC16318 | AG-14361 | 328543-09-5 | >99.00% | |
A PARP1 inhibitor | ||||
| GC16725 | AZ6102 | 1645286-75-4 | >99.50% | |
A TNKS1/2 inhibitor | ||||
| GC16914 | MN 64 | 92831-11-3 | >99.50% | |
A TNKS inhibitor | ||||
| GC17555 | NVP-TNKS656 | 1419949-20-4 | >98.00% | |
A TNKS2 inhibitor | ||||
| GC18172 | E7449 | 1140964-99-3 | >98.00% | |
An inhibitor of PARP1, PARP2, and TNKS1/2 | ||||
| GC19264 | NMS-P118 | 1262417-51-5 | >99.50% | |
A potent and selective PARP1 inhibitor | ||||
| GC19505 | RK-287107 | 2171386-10-8 | >99.50% | |
A TNKS1/2 inhibitor | ||||
| GC19542 | GeA-69 | 2143475-98-1 | >99.50% | |
GeA-69 是一种多聚腺苷二磷酸核糖聚合酶 14 (PARP14) 的选择性变构抑制剂,靶向大结构域 2 (MD2),Kd 值为 2.1 µM。 GeA-69 参与 DNA 损伤修复机制并阻止 PARP14 MD2 募集到激光诱导的 DNA 损伤部位。 | ||||
| GC32793 | Rucaparib Camsylate | 1859053-21-6 | >99.50% | |
A PARP1 inhibitor | ||||
| GC33223 | BRCA1-IN-1 | 1622262-74-1 | - | |
BRCA1-IN-1是一种新型的小分子BRCA1抑制剂,IC50和Ki分别为0.53μM和0.71μM。 | ||||
| GC33358 | WD2000-012547 | 283172-68-9 | - | |
WD2000-012547是一种选择性的PARP-1抑制剂,pKi为8.221。 | ||||
| GC34071 | Pamiparib (BGB-290) | 1446261-44-4 | >99.50% | |
Pamiparib (BGB-290)是一种强效口服的聚腺苷二磷酸核糖聚合酶(PARP)抑制剂,对PARP-1和PARP-2的IC 50 值分别为1.3nM和0.9nM。 | ||||
| GC34120 | Niraparib R-enantiomer (MK 4827 (R-enantiomer)) | 1038915-58-0 | >99.50% | |
Niraparib R-enantiomer (MK-4827 R-enantiomer) 是一种出色的 PARP1 抑制剂,IC50 为 2.4 nM。 | ||||
